News
HQH
19.80
-2.85%
-0.58
Press Release: Aberdeen Investments U.S. -2-
Dow Jones · 2d ago
Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Dow Jones · 2d ago
Weekly Report: what happened at HQH last week (0921-0925)?
Weekly Report · 4d ago
Weekly Report: what happened at HQH last week (0914-0918)?
Weekly Report · 09/21 09:50
Real Estate On Sale: Locking In +9% Cash Yields
Seeking Alpha · 09/19 14:30
HQH: Over 10% Yield On This Healthcare Fund
Seeking Alpha · 09/18 13:30
Weekly Report: what happened at HQH last week (0907-0911)?
Weekly Report · 09/14 09:53
Weekly Report: what happened at HQH last week (0831-0904)?
Weekly Report · 09/07 09:49
Weekly Report: what happened at HQH last week (0824-0828)?
Weekly Report · 08/31 09:54
abrdn Healthcare Investors Q2 2026 Commentary
Seeking Alpha · 08/25 01:20
Weekly Report: what happened at HQH last week (0817-0821)?
Weekly Report · 08/24 09:54
Opportunity To Catch 2 Income Picks Before Their Yield Goes Higher
Seeking Alpha · 08/22 14:30
Weekly Report: what happened at HQH last week (0810-0814)?
Weekly Report · 08/17 09:55
abrdn Healthcare Investors declares $0.66 dividend
Seeking Alpha · 08/12 06:45
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
Dow Jones · 08/11 20:17
Press Release: Certain Aberdeen Investments U.S. -2-
Dow Jones · 08/11 20:17
Weekly Report: what happened at HQH last week (0803-0807)?
Weekly Report · 08/10 09:52
HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy
Seeking Alpha · 08/07 21:58
2 Lower-Risk Fat Dividends You Can't Ignore
Seeking Alpha · 08/03 11:35
Weekly Report: what happened at HQH last week (0727-0731)?
Weekly Report · 08/03 09:51
More
Webull provides a variety of real-time HQH stock news. You can receive the latest news about abrdn Healthcare Investors through multiple platforms. This information may help you make smarter investment decisions.
About HQH
Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture, and environmental management. The Fund invests primarily in securities of public and private companies, which have potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of the United States issuers that are traded primarily in foreign markets. The Fund's investment advisor is Tekla Capital Management LLC.